Search

Search Constraints

You searched for: Author/Creator Podoltsev, Nikolai A.

Search Results

1. A case of acute myeloid leukemia with unusual germline CEBPA mutation: lessons learned about mutation detection, location, and penetrance. Issue 5 (16th April 2021)

2. A Phase I dose‐escalation study of DCLL9718S, an antibody‐drug conjugate targeting C‐type lectin‐like molecule‐1 (CLL‐1) in patients with acute myeloid leukemia. Issue 5 (11th March 2021)

3. Association of provider experience and clinical outcomes in patients with myelodysplastic syndromes receiving hypomethylating agents. Issue 2 (28th January 2020)

4. Clinical effectiveness of DNA methyltransferase inhibitors and lenalidomide in older patients with refractory anemia with ring sideroblasts: a population-based study in the United States. Issue 10 (24th August 2021)

5. Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experience*. Issue 9 (28th July 2020)

6. Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes. (21st September 2016)

7. Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United States. (November 2021)

8. Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United States. (October 2021)

9. Cost-effectiveness of azacitidine and ivosidenib in newly diagnosed older, intensive chemotherapy-ineligible patients with IDH1-mutant acute myeloid leukemia. Issue 2 (28th January 2023)